Anti-fibroblast growth factor-2 antibodies attenuate mechanical allodynia in a rat model of neuropathic pain

J Mol Neurosci. 2005;27(3):315-24. doi: 10.1385/JMN:27:3:315.

Abstract

Peripheral nerve injury leads to the activation of spinal cord astrocytes, which contribute to maintaining neuropathic (NP) pain behavior. Fibroblast growth factor-2 (FGF-2), a neurotrophic and gliogenic factor, is upregulated by spinal cord astrocytes in response to ligation of spinal nerves L5 and L6 (spinal nerve ligation [SpNL]). To evaluate the contribution of spinal astroglial FGF-2 to mechanical allodynia following SpNL, neutralizing antibodies to FGF-2 were injected intrathecally. Administration of 18 microg of anti-FGF-2 antibodies attenuated mechanical allodynia at day 21 after SpNL and reduced FGF-2 and glial acidic fibrillary protein mRNA expression and immunoreactivity in the L5 spinal cord segment of rats with SpNL. These results suggest that endogenous astroglial FGF-2 contributes to maintaining NP tactile allodynia associated with reactivity of spinal cord astrocytes and that inhibition of spinal FGF-2 ameliorates NP pain signs.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies / administration & dosage
  • Astrocytes / cytology
  • Astrocytes / metabolism*
  • Fibroblast Growth Factor 2 / genetics
  • Fibroblast Growth Factor 2 / immunology
  • Fibroblast Growth Factor 2 / metabolism*
  • Glial Fibrillary Acidic Protein / genetics
  • Glial Fibrillary Acidic Protein / metabolism
  • Hyperesthesia / physiopathology*
  • Injections, Spinal
  • Male
  • Neuralgia / physiopathology*
  • Pain / physiopathology
  • Pain Measurement
  • Peripheral Nerve Injuries
  • Rats
  • Rats, Sprague-Dawley
  • Spinal Cord / cytology

Substances

  • Antibodies
  • Glial Fibrillary Acidic Protein
  • Fibroblast Growth Factor 2